ALK-positive
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC (NCT06569420) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2021-12-31 |
| Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer (NCT05132218) | Peking University Cancer Hospital & Institute | 2021-10-19 |
| Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer (NCT02321501) | M.D. Anderson Cancer Center | 2016-06-22 |
| Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) (NCT02201992) | ECOG-ACRIN Cancer Research Group | 2015-03-23 |
| Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer (NCT02227940) | Roswell Park Cancer Institute | 2015-01-08 |
Track ALK-positive automatically
Every clearance here is in the API, with alerts when new ones post.